NEW YORK, March 20, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of securities of Geron Corporation (NASDAQ: GERN) between June 7, 2024 and February 25, 2025, both dates inclusive (the “Class…
Category: Uncategorized
NEW YORK, March 20, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering…
NEW YORK, March 20, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the “Class…
NEW YORK, March 20, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Monolithic Power Systems, Inc. (NASDAQ: MPWR) between February 8, 2024 and November 8, 2024, both dates inclusive (the “Class Period”), of the important April…
NEW YORK, March 20, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FMC Corporation (NYSE: FMC) between November 16, 2023 and February 4, 2025, both dates inclusive (the “Class Period”), of the important April 14, 2025 lead…
NEW YORK, March 20, 2025 /PRNewswire/ — Standard Motor Products, Inc. (SMP) is pleased to share the expansion of its Standard® Gasoline Fuel Injector program. Standard® Fuel Injectors are 100% new, never remanufactured, and deliver OE-matching spray patterns and flow rates to help…
Special Guest Speakers Vivek Ramaswamy and Trump Pollster Jim McLaughlin 2025 Gov. Candidates Bramnick, Ciattarelli, Durr, Kranjac Featured Educational Training Sessions for Candidates, Volunteers, Political Operatives Networking, Social Events Fri. and Sat. at Caesars Atlantic City…
TREMFYA® is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous induction regimen Supported by data from the GALAXI study, TREMFYA® is the only IL-23i to show superiority versus STELARA® in all pooled endoscopic endpoints…
New Line Produces 1,500 Cans Per Minute Generating 15M+ Cases of Supplemental Brewery Production Annually ROCHESTER, N.Y., March 20, 2025 /PRNewswire/ — FIFCO USA, parent company of the Genesee Brewery, celebrated the unveiling of its new $28 million can line today with a ribbon-cutting…
SAN FRANCISCO, March 20, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference: H.C. Wainwright 3rd Annual Autoimmune &…